Please login to the form below

Not currently logged in
Email:
Password:

Dr Keith Bragman joins Alacrita

He becomes a partner at the firm’s London office

Alacrita Dr Keith BragmanLife sciences consultancy Alacrita has appointed Dr Keith Bragman as a partner in its London office.

Dr Bragman brings a wealth of industry experience to the firm, having served on the Science and Technology Select Committee at the House of Commons, worked with the Bill and Melinda Gates Foundation and at the UK government's department for international development.

He has held a number of senior leadership positions at pharmaceutical companies, including serving as head of global development and research for UCB's Japanese business, vice president and senior partner for biotechnology at Quintiles, and European head of clinical oncology at Bristol-Myers Squibb.

Managing partner Anthony Walker said: “We are delighted to welcome Keith to our product development practice as we build a best-in-class consulting practice to help companies develop better therapeutics.

“Keith is an experienced executive with deep and broad knowledge of the drug development process and a sound understanding of the challenges faced by senior management.

“He joins a high calibre team of seasoned consultants and underlines our commitment to providing exceptionally high quality advice to the industry.”

30th June 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics